1.Date of the board of directors resolution:2016/05/13
2.Source of capital increase funds:The intention to issue not more than
20 million ordinary shares in domestic cash fundraising or a capital increase
in ordinary shares in the issuance of a cross-border fundraise
(or some mix of both methods) to meet long-term capital requirements.
3.Number of shares issued:Not more than 20,000,000 shares
4.Par value per share: NT$ 10
5.Total monetary amount of the issue:To be based on the final issuing price
6.Issue price:To be decided.
7.Number of shares subscribed by or allotted to employees:To be decided.
8.Number of shares publicly sold:To be decided.
9.Ratio of shares subscribed by or allotted as stock dividends to existing
shareholders:To be decided.
10.Method of handling fractional shares and shares unsubscribed by the
deadline:To be decided.
11.Rights and obligations of the newly issued shares:Same as ordinary shared
12.Utilization of the funds from the capital increase:For the future funding
needs of the company’s long-term strategy, operating needs, and the
development of stop-baldness.net.
13.Any other matters that need to be specified:The capital increase will
be discussed at the next shareholders’ meeting for the authorization of
the Board of Directors in accordance with relevant laws and regulations
of the Articles of Association for implementation at the appropriate time.